Inverse Micellar Sugar Glass (IMSG) Nanoparticles for Transfollicular Vaccination

    March 2015 in “ Journal of controlled release
    Ankit Mittal, Kai Schulze, Thomas Ebensen, Sebastian Weißmann, Steffi Hansen, Carlos A. Guzmán, Claus‐Michael Lehr
    Studysummary This study found that transfollicular delivery using surfactant-based nanoparticles significantly enhanced antigen stability and immune response compared to other delivery methods, especially when combined with an adjuvant.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This study demonstrated the potential of using inverse micellar sugar glass (IMSG) nanoparticles for transfollicular (TF) vaccination as a needle-free method. The IMSG nanoparticles showed enhanced stability and encapsulation efficacy for the model antigen ovalbumin (OVA) compared to other nanoparticle systems. When administered via the TF route, these nanoparticles achieved better follicular uptake and elicited significant humoral and cellular immune responses, especially when co-encapsulated with the adjuvant c-di-AMP. This highlighted the importance of optimized nanocarriers and adjuvants for effective TF vaccination. The study underscored the potential of TF vaccination using nanoparticles to deliver antigens through intact skin, offering a promising alternative to traditional vaccination methods.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results